Morning Ireland podcast

Weight-loss drug Mounjaro not value for money for public patients, finds study

0:00
8:14
Rewind 15 seconds
Fast Forward 15 seconds
Professor Michael Barry, Clinical Director for the National Centre for Pharmacoeconomics, on the cost of making the weight loss drug Mounjaro available to public patients.

See omnystudio.com/listener for privacy information.

More episodes from "Morning Ireland"